Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary

American Journal of Surgical Pathology

Volumn 32, Issue 4, 2008, Pages 600-607

  Esheba, Ghada E ^a   Pate, Lisa L ^a   Longacre, Teri A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AFP; CK7; Clear cell carcinoma; Endodermal sinus tumor; Glypican 3; Immunohistochemistry; Ovary; Yolk sac tumor

Indexed keywords

GLYPICAN 3; ONCOFETAL ANTIGEN;

ARTICLE; CELL DIFFERENTIATION; FEMALE; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; OVARY CELL; PROTEIN EXPRESSION; SEX CORD TUMOR; STAINING; SYNCYTIOTROPHOBLAST; TISSUE MICROARRAY; YOLK SAC TUMOR;

ALPHA-FETOPROTEINS; ANTIGENS, NEOPLASM; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; ENDODERMAL SINUS TUMOR; FEMALE; GLYPICANS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-7; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 41449096642     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31815a565a     Document Type: Article

References (46)

1. Abe A, Furumoto H, Yoshida K, et al. A case of ovarian endometrioid adenocarcinoma with a yolk sac tumor component. Int J Gynecol Cancer. 2007. [Epub ahead of print].
2. Baer C, Nees M, Breit S, et al. Profiling and functional annotation of mRNA gene expression in pediatric rhabdomyosarcoma and Ewing's sarcoma. Int J Cancer. 2004;110:687-694.
3. Capurro M, Wanless IR, Sherman M, et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology. 2003;125:89-97.
4. Clement PB, Young RH, Scully RE. Endometrioid-like variant of ovarian yolk sac tumor. A clinicopathological analysis of eight cases. Am J Surg Pathol. 1987;11:767-778.
5. Devouassoux-Shisheboran M, Schammel DP, Tavassoli FA. Ovarian hepatoid yolk sac tumours: morphological, immunohistochemical and ultrastructural features. Histopathology. 1999;34: 462-469.
6. Eglen DE, Ulbright TM. The differential diagnosis of yolk sac tumor and seminoma. Usefulness of cytokeratin, alpha-fetoprotein, and alpha-1-antitrypsin immunoperoxidase reactions. Am J Clin Pathol. 1987;88:328-332.
7. Filmus J. Glypicans in growth control and cancer. Glycobiology. 2001;11:19R-23R.
8. Grozdanov PN, Yovchev MI, Dabeva MD. The oncofetal protein glypican-3 is a novel marker of hepatic progenitor/oval cells. Lab Invest. 2006;86:1272-1284.
9. Higuchi Y, Kouno T, Teshima H, et al. Serous papillary cystadenocarcinoma associated with alpha-fetoprotein production. Arch Pathol Lab Med. 1984;108:710-712.
10. Hishinuma M, Ohashi KI, Yamauchi N, et al. Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alphafetoprotein-producing gastric carcinoma. Histopathology. 2006;49: 479-486.
11. Horiuchi A, Osada R, Nakayama K, et al. Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53. Gynecol Oncol. 1998;70:295-299.
12. Kammerer-Doak D, Baurick K, Black W, et al. Endodermal sinus tumor and embryonal carcinoma of the ovary in a 53-year-old woman. Gynecol Oncol. 1996;63:133-137.
13. Kamoi S, Ohaki Y, Mori O, et al. A case of ovarian endometrioid adenocarcinoma with yolk sac tumor component in a postmenopausal woman. Apmis. 2002;110:508-514.
14. Kim H, Xu GL, Borczuk AC, et al. The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor. Am J Respir Cell Mol Biol. 2003;29:694-701.
15. Kinoshita K. A 62-year-old woman with endodermal sinus tumor of the ovary. Am J Obstet Gynecol. 1990;162:760-762.
16. Konishi I, Fujii S, Kataoka N, et al. Ovarian mucinous cystadenocarcinoma producing alpha-fetoprotein. Int J Gynecol Pathol. 1988; 7:182-189.
17. Kurman RJ, Norris HJ. Endodermal sinus tumor of the ovary: a clinical and pathologic analysis of 71 cases. Cancer. 1976;38: 2404-2419.
18. Kuwashima Y, Uehara T, Kishi K, et al. Immunohistochemical characterization of undifferentiated carcinomas of the ovary. J Cancer Res Clin Oncol. 1994;120:672-677.
19. Lin H, Huber R, Schlessinger D, et al. Frequent silencing of the GPC3 gene in ovarian cancer cell lines. Cancer Res. 1999;59: 807-810.
20. Lopez JM, Malpica A, Deavers MT, et al. Ovarian yolk sac tumor associated with endometrioid carcinoma and mucinous cystadenoma of the ovary. Ann Diagn Pathol. 2003;7:300-305.
21. Mast AE, Higuchi DA, Huang ZF, et al. Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor. Biochem J. 1997;327(Pt 2):577-583.
22. Mazur MT, Talbot WH Jr, Talerman A. Endodermal sinus tumor and mucinous cystadenofibroma of the ovary. Occurrence in an 82-year-old woman. Cancer. 1988;62:2011-2015.
23. McBee WC Jr, Brainard J, Sawady J, et al. Yolk sac tumor of the ovary associated with endometrioid carcinoma with metastasis to the vagina: a case report. Gynecol Oncol. 2007;105:244-247.
24. Murthy SS, Shen T, De Rienzo A, et al. Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma. Oncogene. 2000;19:410-416.
25. Nakatsura T, Nishimura Y. Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma. BioDrugs. 2005;19:71-77.
26. Nakatsura T, Yoshitake Y, Senju S, et al. Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. Biochem Biophys Res Commun. 2003;306:16-25.
27. Nogales FF, Bergeron C, Carvia RE, et al. Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm. Analysis of six cases. Am J Surg Pathol. 1996;20: 1056-1066.
28. Nomura K, Miyasaka Y, Murae M, et al. Ovarian mucinous cystadenocarcinoma producing alpha-fetoprotein. A case report. Acta Pathol Jpn. 1992;42:372-375.
29. Oh C, Kendler A, Hernandez E. Ovarian endodermal sinus tumor in a postmenopausal woman. Gynecol Oncol. 2001;82:392-394.
30. Ota S, Hishinuma M, Yamauchi N, et al. Oncofetal protein glypican-3 in testicular germ-cell tumor. Virchows Arch. 2006;449: 308-314.
31. Pilia G, Hughes-Benzie RM, MacKenzie A, et al. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet. 1996;12:241-247.
32. Ramalingam P, Malpica A, Silva EG, et al. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas. Am J Surg Pathol. 2004;28: 1499-1505.
33. Rutgers JL, Young RH, Scully RE. Ovarian yolk sac tumor arising from an endometrioid carcinoma. Hum Pathol. 1987;18:1296-1299.
34. Saikali Z, Sinnett D. Expression of glypican 3 (GPC3) in embryonal tumors. Int J Cancer. 2000;89:418-422.
35. Schiller W. Mesonephroma ovarii. Am J Cancer. 1939;35:1-21.
36. Scully RE, Young RH, Clement PB. Atlas of Tumor Pathology. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament. Washington, DC: Armed Forces Institute of Pathology; 1998:141-151.
37. Scully RE, Clement PB, Young RH. Ovarian surface epithelialstromal tumors. In: Mills SE, ed. Sternberg's Diagnostic Surgical Pathology. New York, NY: Lippincott Williams and Wilkins; 2004:2543-2578.
38. Song HH, Shi W, Filmus J. OCI-5/rat glypican-3 binds to fibroblast growth factor-2 but not to insulin-like growth factor-2. J Biol Chem. 1997;272:7574-7577.
39. Song HH, Shi W, Xiang YY, et al. The loss of glypican-3 induces alterations in Wnt signaling. J Biol Chem. 2005;280:2116-2125.
40. Toretsky JA, Zitomersky NL, Eskenazi AE, et al. Glypican-3 expression in Wilms tumor and hepatoblastoma. J Pediatr Hematol Oncol. 2001;23:496-499.
41. Ulbright TM. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol. 2005;18(suppl 2): S61-S79.
42. Ulbright TM, Roth LM, Brodhecker CA. Yolk sac differentiation in germ cell tumors. A morphologic study of 50 cases with emphasis on hepatic, enteric, and parietal yolk sac features. Am J Surg Pathol. 1986;10:151-164.
43. Xiang YY, Ladeda V, Filmus J. Glypican-3 expression is silenced in human breast cancer. Oncogene. 2001;20:7408-7412.
44. Yamauchi N, Watanabe A, Hishinuma M, et al. The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. Mod Pathol. 2005;18:1591-1598.
45. Zirker TA, Silva EG, Morris M, et al. Immunohistochemical differentiation of clear-cell carcinoma of the female genital tract and endodermal sinus tumor with the use of alpha-fetoprotein and Leu-M1. Am J Clin Pathol. 1989;91:511-514.
46. Zynger DL, Dimov ND, Luan C, et al. Glypican 3: a novel marker in testicular germ cell tumors. Am J Surg Pathol. 2006;30: 1570-1575.